Nucleic Acids Research, Vol 26, Issue 9 2069-2074, Copyright © 1998 by Oxford University Press
G Tosquellas, K Alvarez, C Dell'Aquila, F Morvan, JJ Vasseur, JL Imbach and B Rayner
A modified phosphoramidite method has been designed for the solid-phase
synthesis of two dodecathymidine phosphotriesters and two dodecathymidine
thionophosphotriesters. In these analogs, each internucleoside link bears
an S -acyl-2-thioethyl (Me-SATE or tBu-SATE) group removable upon esterase
activation. Efficient synthesis of these lipophilic analogs was achieved
thanks to the use of a photolabile linker anchored to the solid support in
combination with thymidine-3'- O -phosphoramidites having a SATE group in
place of the regular 2- cyanoethyl one. Both dodecathymidine
phosphotriester and thionophosphotriester having S -acetyl-2-thioethyl
groups were found to be stable in the presence of snake venom and calf
spleen phosphodiesterases whereas, upon incubation in CEM cell extracts,
they were selectively hydrolyzed to the anionic parent dodecathymidylate
and dodecathymidine phosphorothioate, respectively. In addition, Me-SATE-
protected dodecathymidine thionophosphotriester was stable in mouse and
human sera as well as in human gastric juice. These results depict the
potential of SATE-protected oligonucleotides as prodrugs of antisense
oligonucleotides.
ARTICLES
The pro-oligonucleotide approach: solid phase synthesis and preliminary evaluation of model pro-dodecathymidylates
Laboratoire de Chimie Bio-Organique, UMR CNRS-UMII 5625, Universite de Montpellier II, Place Eugene Bataillon, 34095 Montpellier Cedex 5, France.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Sen and P. E. Nielsen On the stability of peptide nucleic acid duplexes in the presence of organic solvents Nucleic Acids Res., May 11, 2007; 35(10): 3367 - 3374. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grajkowski, J. Pedras-Vasconcelos, V. Wang, C. Ausin, S. Hess, D. Verthelyi, and S. L. Beaucage Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs Nucleic Acids Res., June 21, 2005; 33(11): 3550 - 3560. [Abstract] [Full Text] [PDF] |
||||
